Examination of the preclinical antinociceptive efficacy of buprenorphine and its designation as full- or partial-agonist
- 1 September 2007
- journal article
- Published by Elsevier in Acute Pain
- Vol. 9 (3) , 145-152
- https://doi.org/10.1016/j.acpain.2007.07.002
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responsesPain, 2004
- G-Protein Coupling and Efficacy of Mu-Opioid Agonists: Relationship to Behavioral EfficacyReviews in Analgesia, 2004
- The [35S]GTPγS binding assay: approaches and applications in pharmacologyPublished by Elsevier ,2003
- Modulation of Guanosine-5′-O-(3-[35S]thio)triphosphate ([35S]GTP-γ-S) Binding by Opioid Agonists and AntagonistsReviews in Analgesia, 2003
- Differential right shifts in the dose-response curve for intrathecal morphine and sufentanil as a function of stimulus intensityPain, 1995
- Pharmacological profile of the potentiation of opioid analgesia by restraint stressPharmacology Biochemistry and Behavior, 1990
- Buprenorphine: Characteristics of binding sites in the rat central nervous systemLife Sciences, 1981
- BuprenorphineDrugs, 1979
- Novel analgesics and molecular rearrangements in the morphine-thebaine group. III. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeineJournal of the American Chemical Society, 1967
- Novel analgesics and molecular rearrangements in the morphine-thebaine group. II. Alcohols derived from 6,14-endo-etheno- and 6,14-endo-ethanotetrahydrothebaineJournal of the American Chemical Society, 1967